|
1
|
Frey N, Katus HA, Olson EN and Hill JA:
Hypertrophy of the heart: A new therapeutic target? Circulation.
109:1580–1589. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosendorff C: Hypertension and coronary
artery disease: A summary of the American Heart Association
scientific statement. J Clin Hypertens (Greenwich). 9:790–795.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Frenneaux MP: Assessing the risk of sudden
cardiac death in a patient with hypertrophic cardiomyopathy. Heart.
90:570–575. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Artham SM, Lavie CJ, Milani RV and Ventura
HO: Obesity and hypertension, heart failure, and coronary heart
disease-risk factor, paradox, and recommendations for weight loss.
Ochsner J. 9:124–132. 2009.PubMed/NCBI
|
|
5
|
Halabchi F, Seif-Barghi T and Mazaheri R:
Sudden cardiac death in young athletes; a literature review and
special considerations in Asia. Asian J Sports Med. 2:1–15. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang P, Mao B, Luo W, Wei B, Jiang W, Liu
D, Song L, Ji G, Yang Z, Lai YQ and Yuan Z: The alteration of
Hippo/YAP signaling in the development of hypertrophic
cardiomyopathy. Basic Res Cardiol:. 109:4352014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu X, Jiang T, Piao C, Li X, Guo J, Zheng
S, Zhang X, Cai T and Du J: Screening mutations of MYBPC3 in 114
unrelated patients with hypertrophic cardiomyopathy by targeted
capture and next-generation sequencing. Sci Rep. 5:114112015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marian AJ: Contemporary treatment of
hypertrophic cardiomyopathy. Tex Heart Inst J. 36:194–204.
2009.PubMed/NCBI
|
|
9
|
Ehlermann P, Weichenhan D, Zehelein J,
Steen H, Pribe R, Zeller R, Lehrke S, Zugck C, Ivandic BT and Katus
HA: Adverse events in families with hypertrophic or dilated
cardiomyopathy and mutations in the MYBPC3 gene. BMC Med Genet.
9:952008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Z, Gerstein M and Snyder M: RNA-Seq:
A revolutionary tool for transcriptomics. Nat Rev Genet. 10:57–63.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saliba AE, Westermann AJ, Gorski SA and
Vogel J: Single-cell RNA-seq: Advances and future challenges.
Nucleic Acids Res. 42:8845–8860. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cui Y and Paules RS: Use of
transcriptomics in understanding mechanisms of drug-induced
toxicity. Pharmacogenomics. 11:573–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ozsolak F and Milos PM: RNA sequencing:
Advances, challenges and opportunities. Nat Rev Genet. 12:87–98.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Podnar J, Deiderick H, Huerta G and
Hunicke-Smith S: Next-generation sequencing RNA-seq library
construction. Curr Protoc Mol Biol. 106:1–19. 2014.PubMed/NCBI
|
|
15
|
Wei X, Ju X, Yi X, Zhu Q, Qu N, Liu T,
Chen Y, Jiang H, Yang G, Zhen R, et al: Identification of sequence
variants in genetic disease-causing genes using targeted
next-generation sequencing. PloS One. 6:e295002011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li R, Yu C, Li Y, Lam TW, Yiu SM,
Kristiansen K and Wang J: SOAP2: An improved ultrafast tool for
short read alignment. Bioinformatics. 25:1966–1967. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Conesa A, Götz S, García-Gómez JM, Terol
J, Talón M and Robles M: Blast2GO: A universal tool for annotation,
visualization and analysis in functional genomics research.
Bioinformatics. 21:3674–3676. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mortazavi A, Williams BA, McCue K,
Schaeffer L and Wold B: Mapping and quantifying mammalian
transcriptomes by RNA-Seq. Nat Methods. 5:621–628. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tarazona S, García-Alcalde F, Dopazo J,
Ferrer A and Conesa A: Differential expression in RNA-seq: A matter
of depth. Genome Res. 21:2213–2223. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ye J, Fang L, Zheng H, Zhang Y, Chen J,
Zhang Z and Wang J, Li S, Li R, Bolund L and Wang J: WEGO: A web
tool for plotting GO annotations. Nucleic Acids Res. 34:(Web Server
issue). W293–W297. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pan JB, Hu SC, Shi D, Cai MC, Li YB, Zou Q
and Ji ZL: PaGenBase: A pattern gene database for the global and
dynamic understanding of gene function. PloS One. 8:e807472013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ho CY: Hypertrophic cardiomyopathy. Heart
Fail Clin. 6:141–159. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gersh BJ, Maron BJ, Bonow RO, Dearani JA,
Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, et
al: 2011 ACCF/AHA guideline for the diagnosis and treatment of
hypertrophic cardiomyopathy: Executive summary: A report of the
American college of cardiology foundation/american heart
association task force on practice guidelines. Circulation.
124:2761–2796. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roma-Rodrigues C and Fernandes AR:
Genetics of hypertrophic cardiomyopathy: Advances and pitfalls in
molecular diagnosis and therapy. Appl Clin Genet. 7:195–208.
2014.PubMed/NCBI
|
|
26
|
Oren A, Toporik A, Biton S, Almogy N,
Eshel D, Bernstein J, Savitsky K and Rotman G: hCHL2, a novel
chordin-related gene, displays differential expression and complex
alternative splicing in human tissues and during myoblast and
osteoblast maturation. Gene. 331:17–31. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu I and Moses MA: BNF-1, a novel gene
encoding a putative extracellular matrix protein, is overexpressed
in tumor tissues. Gene. 311:105–110. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kok LD, Tsui SK, Waye M, Liew CC, Lee CY
and Fung KP: Cloning and characterization of a cDNA encoding a
novel fibroblast growth factor preferentially expressed in human
heart. Biochem Biophys Res Commun. 255:717–721. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Elliott P, Andersson B, Arbustini E,
Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B,
McKenna WJ, et al: Classification of the cardiomyopathies: A
position statement from the European Society Of Cardiology Working
Group on Myocardial and Pericardial Diseases. Euro Heart J.
29:270–276. 2008. View Article : Google Scholar
|
|
30
|
Tam SK, Gu W, Mahdavi V and Nadal-Ginard
B: Cardiac myocyte terminal differentiation. Potential for cardiac
regeneration. Ann N Y Acad Sci. 752:72–79. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Varnava AM, Elliott PM, Baboonian C,
Davison F, Davies MJ and McKenna WJ: Hypertrophic cardiomyopathy:
Histopathological features of sudden death in cardiac troponin T
disease. Circulation. 104:1380–1384. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Frey N and Olson EN: Cardiac hypertrophy:
The good, the bad, and the ugly. Annu Rev Physiol. 65:45–79. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Heineke J and Molkentin JD: Regulation of
cardiac hypertrophy by intracellular signalling pathways. Nat Rev
Mol Cell Biol. 7:589–600. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lu B, Tigchelaar W, Ruifrok WP, van Gilst
WH, de Boer RA and Silljé HH: DHRS7c, a novel
cardiomyocyte-expressed gene that is down-regulated by adrenergic
stimulation and in heart failure. Eur J Heart Fail. 14:5–13. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zoll J, Ponsot E, Dufour S, Doutreleau S,
Ventura-Clapier R, Vogt M, Hoppeler H, Richard R and Flück M:
Exercise training in normobaric hypoxia in endurance runners. III.
Muscular adjustments of selected gene transcripts. J Appl Physiol
(1985). 100:1258–1266. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kjaer A and Hesse B: Heart failure and
neuroendocrine activation: Diagnostic, prognostic and therapeutic
perspectives. Clin Physiol. 21:661–672. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang X, Deng KQ, Luo Y, Jiang DS, Gao L,
Zhang XF, Zhang P, Zhao GN, Zhu X and Li H: Tumor necrosis factor
receptor-associated factor 3 is a positive regulator of
pathological cardiac hypertrophy. Hypertension. 66:356–367. 2015.
View Article : Google Scholar : PubMed/NCBI
|
